Home › Compare › MEDIF vs MO

MEDIF vs MO: Dividend Comparison 2026

MEDIF yields 4345.46% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDIF wins by $15969693446288.71M in total portfolio value
10 years
MEDIF
MEDIF
● Live price
4345.46%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15969693446288.79M
Annual income
$15,278,069,441,942,714,000.00
Full MEDIF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — MEDIF vs MO

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDIFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDIF + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MEDIF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF
Annual income on $10K today (after 15% tax)
$369,364.48/yr
After 10yr DRIP, annual income (after tax)
$12,986,359,025,651,306,000.00/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MEDIF beats the other by $12,986,359,025,651,280,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + MO for your $10,000?

MEDIF: 50%MO: 50%
100% MO50/50100% MEDIF
Portfolio after 10yr
$7984846723144.44M
Annual income
$7,639,034,720,971,373,000.00/yr
Blended yield
95.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

MEDIF
No analyst data
Altman Z
-2.9
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys
0
MO buys
0
No recent congressional trades found for MEDIF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDIFMO
Forward yield4345.46% ✓6.36%
Annual dividend / share$2.00$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6% ✓
Portfolio after 10y$15969693446288.79M ✓$80.1K
Annual income after 10y$15,278,069,441,942,714,000.00 ✓$30,159.17
Total dividends collected$15922667488789.34M ✓$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MEDIF vs MO ($10,000, DRIP)

YearMEDIF PortfolioMEDIF Income/yrMO PortfolioMO Income/yrGap
1← crossover$445,246$434,546.44$10,570$780.30+$434.7K → MEDIF
2$18,558,681$18,082,267.04$11,381$1,032.90+$18.55M → MEDIF
3$724,251,944$704,394,155.22$12,535$1,392.73+$724.24M → MEDIF
4$26,465,566,588$25,690,617,008.13$14,193$1,920.91+$26465.55M → MEDIF
5$905,687,152,836$877,368,996,586.58$16,618$2,723.68+$905687.14M → MEDIF
6$29,029,592,495,582$28,060,507,242,048.22$20,263$3,993.80+$29029592.48M → MEDIF
7$871,632,797,918,927$840,571,133,948,653.80$25,936$6,098.36+$871632797.89M → MEDIF
8$24,520,223,407,609,444$23,587,576,313,836,190.00$35,166$9,775.01+$24520223407.57M → MEDIF
9$646,377,574,155,211,500$620,140,935,109,069,400.00$51,026$16,597.78+$646377574155.16M → MEDIF
10$15,969,693,446,288,792,000$15,278,069,441,942,714,000.00$80,113$30,159.17+$15969693446288.71M → MEDIF

MEDIF vs MO: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this MEDIF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHDMEDIF vs JEPIMEDIF vs OMEDIF vs KOMEDIF vs MAINMEDIF vs PMMEDIF vs BTIMEDIF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.